The University of Arizona Health Sciences eNewsletter
September 2018

A $4.4 million grant from the Department of Defense will help researchers test two drug candidates for idiopathic pulmonary fibrosis — a deadly disease with no cure.

We are moving forward with big, bold ideas that leverage the collective strengths of the UA Health Sciences. Next week, we will be communicating additional information on the UAHS strategic plan where you will have the opportunity to share your thoughts and guide this important process.
The UA Mel and Enid Zuckerman College of Public Health has received a $1.25 million, five-year grant from the National Cancer Institute to train students from diverse backgrounds in cancer prevention and control research.
Daniel Derksen, MD, a nationally noted health-care policy and rural health expert, and UA faculty member and administrator, has been appointed associate vice president for health equity, outreach and interprofessional activities at the UA Health Sciences.
Arizona emergency medical technicians’ risk for suicide is 39-percent higher than the general public, according to a new study conducted by UA College of Medicine – Phoenix researchers.
A new four-year National Cancer Institute grant will enable Terry A. Badger, PhD, RN, to study a precision approach to decreasing psychological distress in both cancer patients and their family caregivers during treatment.
Clara Curiel, MD, professor of medicine and vice chief of the Division of Dermatology at the UA College of Medicine – Tucson and director of the UA Cancer Center’s Cutaneous Oncology Program, has been selected by the Arizona Bioindustry Association as the 2018 Arizona Bioscience Researcher of the Year.
Researchers at the UA College of Medicine – Tucson have found that hospitalized infants with congenital heart disease and central sleep apnea are four times more likely to die during their stay in the hospital than infants with congenital heart disease alone.
Ralph F. Fregosi, PhD, was awarded a $1.9 million, five-year grant from the National Institutes of Health to continue his research on the short- and long-term developmental risks of nicotine exposure to pre- and post-natal health.
Noninvasive prenatal testing, one of the newest additions in genomic testing, is a simple blood test that can tell a lot about a baby’s likelihood of having certain genetic conditions.
The UA College of Pharmacy has appointed Wei Wang, PhD, as director of its drug discovery program and professor in the Department of Pharmacology and Toxicology.
The University of Arizona Health Sciences
Twitter YouTube LinkedIn
Give Today